Can I create kit type titrations for blinded studies with open-label periods?

Yes, you can. Create separate kit types for the blinded and open-label periods if the kit type description must be visible to blinded Oracle Clinical One Platform users during the open-label period.

If the kit type descriptions don't need to be visible, you can use blinded kit types during the open-label period and need to create only blinded kit types.

Don't forget to define any kit that was part of the previous kit type titration when you create the transition kits for subjects to move to the open-label period.